Are you looking for Cefixime tablet manufacturer? Than you are at the right destination. Strava Healthcare is a prominent manufacturer and supplier of Cefixime tablets in India majorly for pharmaceutical companies, hospital pharmacies, and export markets. Cefixime is a third-generation oral cephalosporin with solid form Gram-negative coverage, reasonable oral bioavailability, and a twice-daily routine that holds up in outpatient settings. It is a workhorse antibiotic for UTIs, respiratory infections, and uncomplicated gonorrhoea, and a practical choice for typhoid in resource-limited settings where IV options are not there.
GMP-certified manufacturing with assay, dissolution, content uniformity, and microbiological purity testing on every batch. Third-party COAs on request.
Indications
- Urinary tract infections — uncomplicated and lower UTI
- Community-acquired respiratory infections — pharyngitis, sinusitis, bronchitis
- Uncomplicated gonorrhoea
- Typhoid fever
- Acute otitis media in children
For B2B and Pharma Partners
- Contract manufacturing: custom strengths, branding, and packaging
- Private label: film-coated tablets ready to market
- Bulk supply for domestic and export distributors
Product Specifications
| Parameter | Details |
|---|---|
Active Ingredient |
Cefixime (as trihydrate) |
Strengths |
100 mg / 200 mg / 400 mg |
Dosage Form |
Film-coated tablet |
Packaging Sizes |
Blisters of 6s, 10s; bottles of 100s |
Storage |
Below 30°C, protected from moisture |
Shelf Life |
36 months |
Manufacturer |
Strava Healthcare Private Limited |
Frequently Asked Questions
The cross-reactivity risk is lower than older teaching suggested — around 1 to 2% in patients with a documented penicillin allergy. Anaphylaxis history is a different matter and warrants specialist input before proceeding. For milder historical reactions — a rash, some GI upset — cefixime is generally used without issue.
No. Gram-positive coverage, it included Staphylococcus aureus, is poor. For skin and soft tissue infections where staph is the likely pathogen, cefixime is the not appropriate antibiotic. The spectrum is predominantly Gram-negative, and prescribing decisions should reflect that.
Yes. We supply to regulated and semi-regulated markets. Dossier support and COPP are available for import registration.
